Welcome to our dedicated page for Enhabit news (Ticker: EHAB), a resource for investors and traders seeking the latest updates and insights on Enhabit stock.
Enhabit Inc (EHAB) provides essential home health and hospice care services across the United States, delivering Medicare-certified skilled nursing and compassionate end-of-life support directly to patients' homes. This news hub offers investors and industry professionals a centralized source for tracking the company's operational developments and market position.
Access timely updates on earnings reports, strategic partnerships, regulatory compliance milestones, and leadership announcements. Our curated collection includes press releases about service expansions, quality care initiatives, and technology integrations that maintain Enhabit's competitive edge in home-based healthcare.
Key updates cover both segments of Enhabit's operations: home health services focused on rehabilitation and chronic care management, plus hospice services emphasizing patient comfort and family support. Stay informed about operational metrics, industry recognition, and evolving care models without promotional bias.
Bookmark this page for streamlined access to verified information about Enhabit's clinical advancements and financial performance. Check back for objective reporting on how the company navigates healthcare regulations and meets growing demand for personalized home care solutions.
Enhabit (NYSE: EHAB) reported Q3 2025 results for the quarter ended Sept. 30, 2025, with total net service revenue $263.6M, net income $11.1M, Adjusted EBITDA $27.0M, diluted EPS $0.22 and adjusted diluted EPS $0.17.
Key operational highlights: home health same-store admissions +3.6% and ADC +3.7% (Medicare ADC down 1.4%), hospice net service revenue +20.0% to $63.1M with hospice Adjusted EBITDA +72.0% and hospice ADC +12.6%. The company reduced bank debt by $15.0M in the quarter (7th straight quarter of prepayment) and reports a $100.0M reduction vs Q4 2023, yielding ~$19.2M annualized cash interest savings and a reported leverage of 3.9x.
Updated 2025 guidance: net service revenue $1,058–1,063M, Adjusted EBITDA $106–109M, Adjusted EPS $0.50–0.56.
Enhabit (NYSE: EHAB) will participate in the UBS Global Healthcare Conference 2025. Enhabit’s President and CEO Barb Jacobsmeyer and CFO Ryan Solomon will appear in a fireside chat on Tuesday, Nov. 11, 2025 at 11:30 a.m. CT. The session will be webcast live and will be available for replay on Enhabit’s investor website.
Enhabit Home Health & Hospice (NYSE: EHAB) will report third-quarter 2025 results for the period ended Sept. 30, 2025 on Nov 5, 2025 and will host a webcast and conference call on Nov 6, 2025 at 9:00 a.m. ET.
Participants are asked to join 15 minutes early. Call numbers: Toll-free 888-660-6150, International 929-203-0843, Conference ID 5248158. Webcast: https://events.q4inc.com/attendee/991714917. A replay and webcast link will be available on Enhabit’s investor website.
Enhabit operates 249 home health locations and 114 hospice locations across 34 states. Investor contact: investorrelations@ehab.com.
Enhabit (NYSE:EHAB), a leading national home health and hospice provider, has announced its upcoming participation in the Jefferies 2025 Healthcare Services Conference. The company's President and CEO Barb Jacobsmeyer and CFO Ryan Solomon will engage in a fireside chat on Tuesday, September 30, 2025, at 10:55 a.m. CT. Investors can access the live webcast and replay through Enhabit's investor website.
Enhabit (NYSE: EHAB), a leading home health and hospice provider, announced that President and CEO Barb Jacobsmeyer plans to step down from her roles in July 2026 or upon the appointment of a successor. The company has initiated a leadership succession plan and engaged Russell Reynolds Associates to conduct a comprehensive search for the next CEO.
As Enhabit's first CEO, Jacobsmeyer has played a crucial role in stabilizing the business and building momentum. The board has expressed commitment to ensuring a smooth transition while maintaining focus on executing the company's mission of providing high-quality, compassionate patient care.
Enhabit (NYSE: EHAB), a leading home health and hospice provider, reported strong Q2 2025 results with net service revenue of $266.1 million and net income of $5.2 million. The company achieved notable growth metrics, including a 12.3% year-over-year increase in hospice average daily census and 1.3% growth in home health admissions.
Key financial highlights include Adjusted EBITDA of $26.9 million (up 6.7% YoY), earnings per share of $0.10, and adjusted diluted EPS of $0.13. The company strengthened its balance sheet by reducing bank debt by $10.0 million and has increased its full-year 2025 guidance, now projecting revenue between $1,060-$1,073 million and Adjusted EBITDA of $104-$108 million.
Enhabit (NYSE: EHAB), a leading national home health and hospice provider, has scheduled its second quarter 2025 earnings conference call for August 7, 2025, at 10:00 AM EDT. The company will release its financial results for the quarter ended June 30, 2025, on August 6, 2025.
The conference call will be accessible via webcast and telephone, with a toll-free number (888-660-6150) and international number (929-203-0843) available for participants. Enhabit currently operates 251 home health locations and 113 hospice locations across 34 states.
Enhabit (NYSE: EHAB), a leading national home health and hospice provider, has announced its participation in the Goldman Sachs 46th Annual Global Healthcare Conference. The company's President and CEO Barb Jacobsmeyer and CFO Ryan Solomon will engage in a fireside chat on June 10 at 10 a.m. EDT, which will be available via webcast and replay on the company's investor website.
Enhabit operates across 34 states with 251 home health locations and 113 hospice locations, leveraging advanced technology to deliver patient care in home settings.
Enhabit (NYSE: EHAB) reported its Q1 2025 financial results with net service revenue of $259.9 million and net income of $17.8 million, including a $14.7 million gain on sale of investment. The company achieved Adjusted EBITDA of $26.6 million, up 5.1% year over year.
Key highlights include home health non-Medicare admissions increasing 7.4%, hospice average daily census growing 12.3% year over year, and hospice Adjusted EBITDA rising 64.8%. The company reduced bank debt by $25 million in Q1, bringing the leverage ratio below 4.5 times. Home health faced some challenges with Medicare revenue declining 11%, while hospice segment showed strong performance with 20.5% revenue growth.
Enhabit reaffirmed its 2025 guidance with projected net service revenue of $1,050-$1,080 million and Adjusted EBITDA of $101-$107 million.
Enhabit Inc. (NYSE: EHAB), a national home health and hospice provider, has scheduled its first quarter 2025 earnings release and conference call. The company will announce Q1 2025 results on May 7, 2025, followed by a conference call and webcast on May 8, 2025 at 10 a.m. EDT.
Enhabit operates across 34 states with 255 home health locations and 115 hospice locations. The company specializes in home-based patient care, utilizing advanced technology and clinical teams to deliver healthcare services.
FAQ
What is the current stock price of Enhabit (EHAB)?
What is the market cap of Enhabit (EHAB)?
